2025-03-01
2024-05-19
| Summary | |
|---|---|
| Cancer Type | Liver Cancer |
| Grade | II |
| Stage | NA |
| Ethnicity | Asian |
| Gender | M |
| Age | 59 |
| Pathology Diagnosis | Epithelioid malignant tumor, consider hepatocellular carcinoma, grade II, with massive necrosis, nodular cirrhosis, fibrous tissues hyperplasia with part of fibrous septum formation, IHC results: AFP(-), HEPA (-), PDEC( little focus +), P48(-), CD34 (vessel +), CK19 (+), PERK (-), PAKT (-), PMEK1/2(-), CK7(part +). |
| Biopsy Site | Liver |
| Treatment History | NA |
| Pathology QC | Liver adenocarcinoma (Pa), HCC (P2). |
| Special Features | HBV(++); HCV(-). slight BW loss; revival take rate is low |
| Mouse Strain | Balb/c nu |
| TMA | TMA-HP-LI-028 |
| Viral Status in PDX | HBV+, HCV-, HIV- (P5, RNAseq) |
| Available In | CB_CN |
| RNA Seq | P5 |
| Exome Seq | NA |
Already Registered? Login
To view this data, close this window and Log In or Register for Access.
© 2025 Crown Bioscience. All Rights Reserved.
Privacy Policy | Imprint | Terms of Service | Privacy Preferences


© 2025 Crown Bioscience. All Rights Reserved. Privacy Policy